Streetbeat News

Products Services

AHI

CMMB

OCTO

AHI signed a letter of intent with UAE-based e-Script Medicine Management Company Pharmak Direct. Eightco Holdings Inc. (OCTO) raised its revenue guidance to $73 million for FY2023. Chemomab Therapeutics (CMMB) reported positive data from a secondary analysis of a Phase 2a liver fibrosis trial in NASH patients at EASL 2023.

Portfolio Pulse from ryanfaloona@benzinga.com

June 21, 2023 | 12:41 pm

COIN

MARA

RIOT

Crypto-related stocks Coinbase, Marathon Digital, and Riot Platforms are rising amid a surge in the crypto market, driven by positive developments such as the launch of EDX Markets and BlackRock's application for the first spot Bitcoin ETF in the U.S.

Portfolio Pulse from Adam Eckert

June 21, 2023 | 12:41 pm

GSK

GSK announced new data from the AReSVi-006 phase 3 trial, showing that a single dose of Arexvy vaccine is efficacious against RSV-LRTD and severe LRTD in adults aged 60 years and older over two full RSV seasons. The trial also found that revaccination after 12 months does not appear to confer additional benefit for the overall population.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:40 pm

TSLA

Elon Musk, CEO of Tesla Inc, met with Indian Prime Minister Narendra Modi and expressed admiration for him, showing enthusiasm about India's future. Musk is optimistic about Tesla's entry into India and plans to visit the country next year. He also hopes to bring his Starlink Internet service to rural areas in India.

Portfolio Pulse from Shomik Sen Bhattacharjee

June 21, 2023 | 12:40 pm

RCAT

Red Cat Holdings' new military-grade sUAS, the Teal 2, has received clearance from the U.S. Department of Defense (DoD) to be designated as a Blue UAS. The Blue UAS Cleared List is a select group of DoD-approved drones for government users, ensuring they are NDAA compliant, cyber-secure, and safe to fly.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:37 pm

CMMB

Chemomab Therapeutics reported positive secondary Phase 2a liver fibrosis trial results for CM-101 in NASH patients. The data showed improvements in inflammatory and fibrotic biomarkers, with greater biomarker response in high-risk patients. CMMB shares are up 9.2% in premarket trading.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:36 pm

BNED

Barnes & Noble College has launched Be Well. Be You.™, a collection of health and wellness solutions for college students. The initiative aims to address students' physical and mental wellbeing by offering easy access to wellness products in campus bookstores and online.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:35 pm

MSFT

Bill Gates, co-founder of Microsoft, expressed optimism about the potential of artificial intelligence (AI) to revolutionize education during an event in Lagos, Nigeria. He emphasized that AI could simplify complex subjects, assist teachers, and create personalized sets of questions for students.

Portfolio Pulse from Benzinga Newsbot

June 21, 2023 | 12:35 pm

LLY

The FDA has approved Jardiance and Synjardy, new oral medicines for children with type 2 diabetes, providing a new class of treatments. The approvals were granted to Boehringer Ingelheim, which has an alliance with Eli Lilly And Co (NYSE:LLY) in diabetes treatment.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:32 pm

PFE

Pfizer's vaccine demonstrated 78.6% efficacy in preventing RSV-related disease with 3 or more symptoms in the middle of the second RSV season, and 48.9% efficacy in preventing RSV-related disease with 2 or more symptoms.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:32 pm